Saad Usmani, M.D., MBA, FACP Discusses Treatments in Multiple Myeloma Patients

By Rob Dillard - Last Updated: March 31, 2023

DocWire News sat down with Saad Usmani, M.D., MBA, FACP to discuss an indirect treatment comparison study which assesses DARZALEX® (daratumumab) Plus Lenalidomide and Dexamethasone (D-Rd) and Bortezomib-Containing Regimens in Patients with Newly Diagnosed Transplant-Ineligible Multiple Myeloma.

Advertisement

Advertisement